Cardiothoracic & vascular anesthesia

Heparin Activity Following Titration-Guided Protamine Reversal After Cardiopulmonary Bypass: Impact on Postoperative Bleeding

J Cardiothorac Vasc AnesthPublished Prospective controlled clinical study

Authors' conclusion

Residual heparin activity was common after low-dose, titration-guided protamine reversal and related to P/H ratio on ICU arrival. Reappearing heparin activity occurred independently of protamine dosing and was not associated with bleeding.

Study context

Population
Adults undergoing elective coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB), heparin and protamine dosing guided by an automated titration system
Participants
40 adults
Outcome
Residual heparin activity (anti-FXa)
Follow-up
ICU arrival (82 ± 23 minutes after protamine)
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Anti-FXa activity, U/mL (mean ± SD)
0.14 ± 0.15
Patients with detectable anti-factor Xa (anti-FXa)
60%
Mean protamine to heparin (P/H) ratio, mg/100 U
0.54 ± 0.14
P/H ratio vs thrombin time (TT), r
−0.48 (p = 0.004)
P/H ratio vs activated partial thromboplastin time (aPTT), r
−0.50 (p = 0.0015)
P/H ratio vs endogenous thrombin potential, r
0.41 (p = 0.0012)

Observational data: associations, not effects.

Further findings

Reappearing heparin activity (anti-FXa) · 3 hours after intensive care unit (ICU) arrival

Anti-FXa activity increased, U/mL (mean ± SD)
0.18 ± 0.10
Patients with detectable anti-FXa
98%
Independent of P/H ratio

Safety

No association between heparin activity and postoperative bleeding

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Heparin Activity Following Titration-Guided Protamine Reversal After Cardiopulmonary Bypass: Impact on Postoperative Bleeding. J Cardiothorac Vasc Anesth. Published 30 June 2026. doi:10.1053/j.jvca.2026.06.041

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.